adyn CEO Elizabeth Ruzzo launches genetic-and-hormone test this fall to predict birth-control side effects

Elizabeth Ruzzo, founder and CEO of Seattle startup adyn, is launching a fall test that analyzes genetic and hormone data to predict birth-control side effects and reduce trial-and-error prescribing. She aims to make scientific discovery more inclusive by addressing biases in medical research and offering users the option to opt into anonymous research.

Aadyn